Thymosin Alpha-1

Research Peptide

Also known as: Ta1, Zadaxin

What is Thymosin Alpha-1?

Thymosin Alpha-1 is an immune-modulating peptide approved in many countries for hepatitis B/C and as an immune adjuvant.

How It Works

Thymosin Alpha-1 enhances T-cell function, promotes dendritic cell maturation, and modulates cytokine production for balanced immune response.

What Research Shows

Animal Studies

Human Studies

Key Findings:

Approved for hepatitis in 35+ countries
Enhances vaccine response
May support immune function in immunocompromised

Limited Human Research

Most research on Thymosin Alpha-1 has been conducted in animal models. Human clinical trials are limited or absent. Results may not translate directly to humans.

Dosing Protocol

Typical Dose

1.6-3.2 mg

Frequency

2-3 times weekly

Route

Subcutaneous injection

Duration

4-12 weeks

These are general guidelines based on research literature and community protocols. Individual dosing should be determined by a qualified healthcare provider.

Safety & Risks

Reported Side Effects:

Injection site reactionMild flu-like symptoms

Contraindications:

Organ transplant recipients
Severe autoimmune disease

Important: This information is for research purposes only. Always consult with a qualified healthcare provider before using any peptide. Never use peptides without proper medical supervision.

Sourcing & Quality

Quality varies significantly between peptide sources. When sourcing Thymosin Alpha-1, consider:

Third-party testing (HPLC, Mass Spectrometry)
Certificate of Analysis (CoA) availability
Purity levels (>98% recommended)
Beware of LPS (endotoxin) contamination

CalcPep does not sell peptides or recommend specific vendors. Always verify product quality through independent testing.

Quick Facts

Track Your Protocol

Use CalcPep to calculate doses, log injections, and track your progress.

Get CalcPep